Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

Filifactor alocis and Dialister pneumosintes in a Mexican population affected by periodontitis and rheumatoid arthritis: An exploratory study.

Ayala Herrera JL, Apreza Patrón L, Martínez Martínez RE, Domínguez Pérez RA, Abud Mendoza C, Hernández Castro B.

Microbiol Immunol. 2019 Jul 11. doi: 10.1111/1348-0421.12727. [Epub ahead of print]

PMID:
31294852
2.

The frequency and severity of dental caries, and counts of cariogenic bacteria in rheumatoid arthritis patients.

Martinez-Martinez RE, Domínguez-Pérez RA, Sancho-Mata J, Abud-Mendoza C, Ayala-Herrera JL, Popoca-Hernandez EA.

Dent Med Probl. 2019 Apr-Jun;56(2):137-142. doi: 10.17219/dmp/105340.

PMID:
31274251
3.

Live Zoster Vaccine in Patients with Rheumatoid Arthritis Treated with Tofacitinib with or without Methotrexate, or Adalimumab with Methotrexate.

Calabrese LH, Abud-Mendoza C, Lindsey SM, Lee SH, Tatulych S, Takiya L, Iikuni N, Soma K, Luo Z, Fleischmann R.

Arthritis Care Res (Hoboken). 2019 Jun 17. doi: 10.1002/acr.24010. [Epub ahead of print]

PMID:
31207152
4.

Update of the Mexican College of Rheumatology Guidelines for the Pharmacological Treatment of Rheumatoid Arthritis, 2018.

Cardiel MH, Carrillo S, Pérez M, Andrade L, Pacheco Tena C, Silveira LH, Limón L, Cerpa S, Gutiérrez Ureña S, Durán S, Irazoque Palazuelos F, Muñoz López S, Sicsik Ayala SA, Barile L, Ramos Sánchez MA, Grajeda Portes D, Portela M, Hernández Bedolla A, García-Figueroa JL, Montero M, Abud-Mendoza C, Martínez Martínez MU, Herrera van Ostdam D, Pascual-Ramos V, Merayo-Chalico J, Guzmán-Sánchez I, Pérez-Bastidas ME, Aguilar Arreola JE, López Rodríguez A, Reyes-Cordero G, Ricardez HA, Hernández Cabrera MF, Olvera-Soto G, Xibillé Friedmann D.

Reumatol Clin. 2019 May 15. pii: S1699-258X(19)30079-8. doi: 10.1016/j.reuma.2019.04.002. [Epub ahead of print] English, Spanish.

5.

Epidemiologic Profile of Erectile Dysfunction in Patients with Systemic Lupus Erythematosus: The Latin American Landscape.

Merayo-Chalico J, Barrera-Vargas A, Morales-Padilla S, la Garza RR, Vázquez-Rodríguez R, Campos-Guzmán J, Alcocer-Varela J, Sotomayor M, Abud-Mendoza C, Martínez-Martínez M, Colunga-Pedraza I, Uriarte-Hernández C, Acosta-Hernández R, Fajardo D, García-García C, Padilla-Ortíz D, Gómez-Martín D.

J Rheumatol. 2019 Apr;46(4):397-404. doi: 10.3899/jrheum.180292. Epub 2019 Jan 15.

PMID:
30647184
6.
7.

Analysis of Sodium Chloride Intake and Treg/Th17 Lymphocytes in Healthy Individuals and Patients with Rheumatoid Arthritis or Systemic Lupus Erythematosus.

Vitales-Noyola M, Layseca-Espinosa E, Baranda L, Abud-Mendoza C, Niño-Moreno P, Monsiváis-Urenda A, Rosenstein Y, González-Amaro R.

J Immunol Res. 2018 Jul 9;2018:9627806. doi: 10.1155/2018/9627806. eCollection 2018.

8.

Homologies and heterogeneity between Rheumatology Congresses: Mexican, American College of Rheumatology and European League Against Rheumatism.

Cuevas-Orta E, Pedro-Martínez ÁJ, Ramírez-Rodríguez C, Abud-Mendoza C.

Reumatol Clin. 2018 Jun 8. pii: S1699-258X(18)30092-5. doi: 10.1016/j.reuma.2018.04.002. [Epub ahead of print] English, Spanish.

9.

Pulmonary manifestations in systemic lupus erythematosus: pleural involvement, acute pneumonitis, chronic interstitial lung disease and diffuse alveolar hemorrhage.

Aguilera-Pickens G, Abud-Mendoza C.

Reumatol Clin. 2018 Sep - Oct;14(5):294-300. doi: 10.1016/j.reuma.2018.03.012. Review. English, Spanish.

10.

Distribution of Porphyromonas gingivalis fimA genotypes in patients affected by rheumatoid arthritis and periodontitis.

Ayala-Herrera JL, Abud-Mendoza C, Gonzalez-Amaro RF, Espinosa-Cristobal LF, Martínez-Martínez RE.

Acta Odontol Scand. 2018 Oct;76(7):520-524. doi: 10.1080/00016357.2018.1469788. Epub 2018 May 4.

PMID:
29726309
11.

Comorbidities of Inflammatory Arthropathies in the Art of Diego Velázquez.

Ramos-Bello D, Abud-Mendoza C.

J Rheumatol. 2017 Dec;44(12):1878-1879. doi: 10.3899/jrheum.170818. No abstract available.

PMID:
29196547
12.

Analysis of the regulatory function of natural killer cells from patients with systemic lupus erythematosus.

Cruz-González DJ, Gómez-Martin D, Layseca-Espinosa E, Baranda L, Abud-Mendoza C, Alcocer-Varela J, González-Amaro R, Monsiváis-Urenda AE.

Clin Exp Immunol. 2018 Mar;191(3):288-300. doi: 10.1111/cei.13073. Epub 2017 Nov 22.

13.

Patients with Systemic Lupus Erythematosus Show Increased Levels and Defective Function of CD69+ T Regulatory Cells.

Vitales-Noyola M, Oceguera-Maldonado B, Niño-Moreno P, Baltazar-Benítez N, Baranda L, Layseca-Espinosa E, Abud-Mendoza C, González-Amaro R.

Mediators Inflamm. 2017;2017:2513829. doi: 10.1155/2017/2513829. Epub 2017 Sep 6.

14.

Statins in systemic lupus erythematosus.

Abud-Mendoza C.

Ann Rheum Dis. 2018 Sep;77(9):e60. doi: 10.1136/annrheumdis-2017-212463. Epub 2017 Oct 9. No abstract available.

PMID:
28993343
15.

Tofacitinib, an oral Janus kinase inhibitor, in patients from Mexico with rheumatoid arthritis: Pooled efficacy and safety analyses from Phase 3 and LTE studies.

Burgos-Vargas R, Cardiel M, Xibillé D, Pacheco-Tena C, Pascual-Ramos V, Abud-Mendoza C, Mahgoub E, Rahman M, Fan H, Rojo R, García E, Santana K.

Reumatol Clin. 2019 Jan - Feb;15(1):43-53. doi: 10.1016/j.reuma.2017.04.006. Epub 2017 May 25. English, Spanish.

16.

Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial.

Brunner HI, Ruperto N, Tzaribachev N, Horneff G, Chasnyk VG, Panaviene V, Abud-Mendoza C, Reiff A, Alexeeva E, Rubio-Pérez N, Keltsev V, Kingsbury DJ, Del Rocio Maldonado Velázquez M, Nikishina I, Silverman ED, Joos R, Smolewska E, Bandeira M, Minden K, van Royen-Kerkhof A, Emminger W, Foeldvari I, Lauwerys BR, Sztajnbok F, Gilmer KE, Xu Z, Leu JH, Kim L, Lamberth SL, Loza MJ, Lovell DJ, Martini A; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG).

Ann Rheum Dis. 2018 Jan;77(1):21-29. doi: 10.1136/annrheumdis-2016-210456. Epub 2017 May 15.

17.

Diffuse Alveolar Hemorrhage in Autoimmune Diseases.

Martínez-Martínez MU, Oostdam DAH, Abud-Mendoza C.

Curr Rheumatol Rep. 2017 May;19(5):27. doi: 10.1007/s11926-017-0651-y. Review.

PMID:
28397125
18.

Association of cytokines polymorphisms with chronic peridontitis and rheumatoid arthritis in a Mexican population.

Domínguez-Pérez RA, Loyola-Rodriguez JP, Abud-Mendoza C, Alpuche-Solis AG, Ayala-Herrera JL, Martínez-Martínez RE.

Acta Odontol Scand. 2017 May;75(4):243-248. doi: 10.1080/00016357.2017.1280846. Epub 2017 Feb 8.

PMID:
28358286
19.

Urinary sediment suggests lupus nephritis histology.

Martínez-Martínez MU, Llamazares-Azuara LM, Martínez-Galla D, Mandeville PB, Valadez-Castillo F, Román-Acosta S, Borjas-García JA, Abud-Mendoza C.

Lupus. 2017 May;26(6):580-587. doi: 10.1177/0961203316669241. Epub 2016 Sep 29.

PMID:
27687029
20.

IgG4 deposits in pure and combined membranous lupus nephritis.

Herrera van Oostdam D, Martínez Martínez MU, Oros-Ovalle C, Martínez-Gala D, Jaimes Piñón GT, Abud Mendoza C.

Clin Rheumatol. 2016 Jun;35(6):1619-23. doi: 10.1007/s10067-016-3276-z. Epub 2016 May 2.

PMID:
27139512
21.

Are RA patients from a non-endemic HCV population screened for HCV? A cross-sectional analysis of three different settings.

Skinner-Taylor CM, Erhard-Ramírez A, Garza-Elizondo MA, Esquivel-Valerio JA, Abud-Mendoza C, Martínez-Martínez MU, Vega-Morales D, Arana-Guajardo A.

Reumatol Clin. 2017 May - Jun;13(3):156-159. doi: 10.1016/j.reuma.2016.03.006. Epub 2016 Apr 29. English, Spanish.

22.

Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA extension study.

Yoo DH, Prodanovic N, Jaworski J, Miranda P, Ramiterre E, Lanzon A, Baranauskaite A, Wiland P, Abud-Mendoza C, Oparanov B, Smiyan S, Kim H, Lee SJ, Kim S, Park W.

Ann Rheum Dis. 2017 Feb;76(2):355-363. doi: 10.1136/annrheumdis-2015-208786. Epub 2016 Apr 29.

23.

Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study.

Park W, Yoo DH, Miranda P, Brzosko M, Wiland P, Gutierrez-Ureña S, Mikazane H, Lee YA, Smiyan S, Lim MJ, Kadinov V, Abud-Mendoza C, Kim H, Lee SJ, Bae Y, Kim S, Braun J.

Ann Rheum Dis. 2017 Feb;76(2):346-354. doi: 10.1136/annrheumdis-2015-208783. Epub 2016 Apr 26.

24.

Analysis of the Expression and Function of Immunoglobulin-Like Transcript 4 (ILT4, LILRB2) in Dendritic Cells from Patients with Systemic Lupus Erythematosus.

Guerra-de Blas Pdel C, Villaseñor-Talavera YS, Cruz-González Dde J, Baranda L, Doníz-Padilla L, Abud-Mendoza C, González-Amaro R, Monsiváis-Urenda AE.

J Immunol Res. 2016;2016:4163094. doi: 10.1155/2016/4163094. Epub 2016 Feb 22.

25.

Frequency of dental caries in active and inactive systemic lupus erythematous patients: salivary and bacterial factors.

Loyola Rodriguez JP, Galvan Torres LJ, Martinez Martinez RE, Abud Mendoza C, Medina Solis CE, Ramos Coronel S, Garcia Cortes JO, Domínguez Pérez RA.

Lupus. 2016 Oct;25(12):1349-56. doi: 10.1177/0961203316640909. Epub 2016 Apr 5.

PMID:
27053402
26.

A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA study.

Yoo DH, Racewicz A, Brzezicki J, Yatsyshyn R, Arteaga ET, Baranauskaite A, Abud-Mendoza C, Navarra S, Kadinov V, Sariego IG, Hong SS, Lee SY, Park W.

Arthritis Res Ther. 2016 Apr 2;18:82. doi: 10.1186/s13075-016-0981-6.

27.

Comparable long-term efficacy, as assessed by patient-reported outcomes, safety and pharmacokinetics, of CT-P13 and reference infliximab in patients with ankylosing spondylitis: 54-week results from the randomized, parallel-group PLANETAS study.

Park W, Yoo DH, Jaworski J, Brzezicki J, Gnylorybov A, Kadinov V, Sariego IG, Abud-Mendoza C, Escalante WJ, Kang SW, Andersone D, Blanco F, Hong SS, Lee SH, Braun J.

Arthritis Res Ther. 2016 Jan 20;18:25. doi: 10.1186/s13075-016-0930-4.

28.

Considerations on treatment recommendations for rheumatoid arthritis.

Abud-Mendoza C; Grupo Mexicano de Estudio de Manejo Integral de la Artritis Reumatoide.

Reumatol Clin. 2015 Jul-Aug;11(4):193-5. doi: 10.1016/j.reuma.2015.05.002. English, Spanish. No abstract available.

29.

Long-term safety, efficacy, and quality of life in patients with juvenile idiopathic arthritis treated with intravenous abatacept for up to seven years.

Lovell DJ, Ruperto N, Mouy R, Paz E, Rubio-Pérez N, Silva CA, Abud-Mendoza C, Burgos-Vargas R, Gerloni V, Melo-Gomes JA, Saad-Magalhaes C, Chavez-Corrales J, Huemer C, Kivitz A, Blanco FJ, Foeldvari I, Hofer M, Huppertz HI, Job Deslandre C, Minden K, Punaro M, Block AJ, Giannini EH, Martini A; Pediatric Rheumatology Collaborative Study Group and the Paediatric Rheumatology International Trials Organisation.

Arthritis Rheumatol. 2015 Oct;67(10):2759-70. doi: 10.1002/art.39234.

30.

Rheumatoid cachexia and other nutritional alterations in rheumatologic diseases.

Hurtado-Torres GF, González-Baranda LL, Abud-Mendoza C.

Reumatol Clin. 2015 Sep-Oct;11(5):316-21. doi: 10.1016/j.reuma.2015.03.005. Epub 2015 Jun 18. Review. English, Spanish.

31.

Clinical outcomes and risk factors for posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a multicentric case-control study.

Merayo-Chalico J, Apodaca E, Barrera-Vargas A, Alcocer-Varela J, Colunga-Pedraza I, González-Patiño A, Arauz A, Abud-Mendoza C, Martínez-Martínez M, Gómez-Martín D.

J Neurol Neurosurg Psychiatry. 2016 Mar;87(3):287-94. doi: 10.1136/jnnp-2014-310145. Epub 2015 Mar 24.

PMID:
25804426
32.

IgG4-related disease, retrospective histopathological diagnosis. Prevalence in a University Hospital.

Herrera van Oostdam DA, Jaimes Piñón T, Martínez-Martínez MU, Oros-Ovalle C, Aléman-Sánchez N, Abud-Mendoza C.

Reumatol Clin. 2015 Nov-Dec;11(6):335-9. doi: 10.1016/j.reuma.2014.12.007. Epub 2015 Mar 18. English, Spanish.

33.

Proportions of several types of plasma and urine microparticles are increased in patients with rheumatoid arthritis with active disease.

Viñuela-Berni V, Doníz-Padilla L, Figueroa-Vega N, Portillo-Salazar H, Abud-Mendoza C, Baranda L, González-Amaro R.

Clin Exp Immunol. 2015 Jun;180(3):442-51. doi: 10.1111/cei.12598. Epub 2015 Apr 27.

34.

Laboratory biomarkers for guiding therapy with methotrexate in rheumatoid arthritis.

Abud-Mendoza C, Martínez-Martínez MU, Monsiváis-Urenda A, González-Amaro R.

Curr Pharm Des. 2015;21(2):202-11. Review.

PMID:
25163739
35.

Factors associated with mortality and infections in patients with systemic lupus erythematosus with diffuse alveolar hemorrhage.

Martinez-Martinez MU, Sturbaum AK, Alcocer-Varela J, Merayo-Chalico J, Gómez-Martin D, Gómez-Bañuelos Jde J, Saavedra MÁ, Enciso-Peláez S, Faugier-Fuentes E, Maldonado-Velázquez R, Suárez-Larios LM, Vega-Morales D, Casasola-Vargas JC, Carrillo Pérez DL, Abril A, Butendieck R, Irazoque-Palazuelos F, Abud-Mendoza C.

J Rheumatol. 2014 Aug;41(8):1656-61. doi: 10.3899/jrheum.130927. Epub 2014 Jul 1.

PMID:
24986849
36.

Longterm safety, efficacy, and inhibition of structural damage progression over 5 years of treatment with abatacept in patients with rheumatoid arthritis in the abatacept in inadequate responders to methotrexate trial.

Kremer JM, Peterfy C, Russell AS, Emery P, Abud-Mendoza C, Sibilia J, Becker JC, Westhovens R, Genant HK.

J Rheumatol. 2014 Jun;41(6):1077-87. doi: 10.3899/jrheum.130263. Epub 2014 May 1.

37.

Diffuse alveolar hemorrhage in patients with systemic lupus erythematosus. Clinical manifestations, treatment, and prognosis.

Martínez-Martínez MU, Abud-Mendoza C.

Reumatol Clin. 2014 Jul-Aug;10(4):248-53. doi: 10.1016/j.reuma.2014.02.002. Epub 2014 Apr 3. Review. English, Spanish.

38.

[Interstitial lung disease (ILD) in rheumatoid arthritis (RA)].

Abud-Mendoza C, Cuevas-Orta E.

Rev Invest Clin. 2013 Sep-Oct;65(5):455-6. Spanish. No abstract available.

PMID:
24687345
39.

Triple therapy with non-biologic DMARDs for rheumatoid arthritis or biologic therapy. Is it the same?

Abud-Mendoza C, Martínez-Martínez MU.

Reumatol Clin. 2014 Sep-Oct;10(5):345-6. doi: 10.1016/j.reuma.2014.02.006. Epub 2014 Mar 27. No abstract available.

40.

Pulmonary manifestations of granulomatosis with polyangiitis.

Gómez-Gómez A, Martínez-Martínez MU, Cuevas-Orta E, Bernal-Blanco JM, Cervantes-Ramírez D, Martínez-Martínez R, Abud-Mendoza C.

Reumatol Clin. 2014 Sep-Oct;10(5):288-93. doi: 10.1016/j.reuma.2013.12.010. Epub 2014 Feb 14.

41.

Induction of Th17 lymphocytes and Treg cells by monocyte-derived dendritic cells in patients with rheumatoid arthritis and systemic lupus erythematosus.

Estrada-Capetillo L, Hernández-Castro B, Monsiváis-Urenda A, Alvarez-Quiroga C, Layseca-Espinosa E, Abud-Mendoza C, Baranda L, Urzainqui A, Sánchez-Madrid F, González-Amaro R.

Clin Dev Immunol. 2013;2013:584303. doi: 10.1155/2013/584303. Epub 2013 Oct 29.

42.

[Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis: experience with six pediatric patients. Potential efficacy of methotrexate].

Bravo-Oro A, Abud-Mendoza C, Quezada-Corona A, Dalmau J, Campos-Guevara V.

Rev Neurol. 2013 Nov 1;57(9):405-10. Spanish.

43.

Are steroids required for induction therapy and relapses in lupus nephritis?

Abud-Mendoza C, González-Amaro R.

Ann Rheum Dis. 2013 Dec;72(12):e29. doi: 10.1136/annrheumdis-2013-204321. Epub 2013 Aug 13. No abstract available.

PMID:
23942867
44.

Neuropsychiatric manifestations in systemic lupus erythematosus: physiopathogenic and therapeutic basis.

Aguilera-Pickens G, Abud-Mendoza C.

Reumatol Clin. 2013 Nov-Dec;9(6):331-3. doi: 10.1016/j.reuma.2013.02.007. Epub 2013 Jun 7. English, Spanish. No abstract available.

45.

Cutaneous papillomavirus infection in patients with rheumatoid arthritis or systemic lupus erythematosus. A case-control study.

Martínez-Martínez MU, Baranda-Cándido L, Abud-Mendoza C.

Lupus. 2013 Aug;22(9):948-52. doi: 10.1177/0961203313490431. Epub 2013 May 30.

PMID:
23722231
46.

[Calciphylaxis, renal failure and gout. A patient with hyperuricemia as a risk factor for death].

Martínez-Martínez MU, Román-Acosta S, Alvarez-Reyes JM, Oros-Ovalle C, Abud-Mendoza C.

Rev Med Inst Mex Seguro Soc. 2013 Mar-Apr;51(2):218-21. Spanish.

PMID:
23693113
47.

IgG4 (IgG4-RD) related diseases, with a horizon not limited to Mikulicz's disease.

Abud-Mendoza C.

Reumatol Clin. 2013 May-Jun;9(3):133-5. doi: 10.1016/j.reuma.2013.02.003. Epub 2013 Apr 6. English, Spanish. No abstract available.

48.

Lupus nephritis: advances in the knowledge of its immunopathogenesis without the expected therapeutic success?

Abud-Mendoza C.

Reumatol Clin. 2013 Mar-Apr;9(2):77-9. doi: 10.1016/j.reuma.2013.02.001. English, Spanish. No abstract available.

49.

Neuropsychiatric manifestations of systemic lupus erythematosus.

Abud-Mendoza C, Herrera-VAN Oostdam D, Martínez-Martínez MU.

J Rheumatol. 2013 Feb;40(2):204. doi: 10.3899/jrheum.121214. No abstract available.

PMID:
23378497
50.

CKD-EPI is the most reliable equation to estimate renal function in patients with systemic lupus erythematosus.

Martínez-Martínez MU, Mandeville P, Llamazares-Azuara L, Abud-Mendoza C.

Nefrologia. 2013 Jan 18;33(1):99-106. doi: 10.3265/Nefrologia.pre2012.Jun.11101.

Supplemental Content

Loading ...
Support Center